An audit of sugammadex use at a large district general hospital

被引：0

作者：

Richards, C. ^{[1
]}

Lynch, C. ^{[2
]}

Turner, M. ^{[1
]}

机构：

[1] Royal Gwent Hosp, Newport, Gwent, Wales

[2] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales

来源：

ANAESTHESIA | 2014年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

127

引用

页码：74 / 74

页数：1

共 4 条

[1]

Caldwell J, 2011, ADV ANAESTH, V29, P19

[2] Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs [J].

Ledowski, T. ;

Hillyard, S. ;

Kozman, A. ;

Johnston, E. ;

Gillies, E. ;

Greenaway, M. ;

Kyle, B. C. .

ANAESTHESIA AND INTENSIVE CARE, 2012, 40 (02) :340-343

[3] Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome [J].

Ledowski, Thomas ;

Hillyard, Samuel ;

O'Dea, Brendan ;

Archer, Rob ;

Vilas-Boas, Filipe ;

Kyle, Barney .

INDIAN JOURNAL OF ANAESTHESIA, 2013, 57 (01) :46-51

[4] The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital [J].

Watts, R. W. ;

Londont, J. A. ;

van Wijk, R. M. A. W. ;

Lui, Y. -L. .

ANAESTHESIA AND INTENSIVE CARE, 2012, 40 (02) :333-339

← 1 →